PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire•30/10/2026•16:30 ET
0
Key Highlights
- ➤PTC Therapeutics approved inducement awards for 13 new employees
- ➤Stock options cover 9.620 shares at a $63.02 exercise price
- ➤Restricted stock units cover 11,535 shares, vesting over four years
- ➤Options carry 10-year terms and vest over four years
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
WARREN, N.J., Oct. 30, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Oct. 28, 2026, the company approved non-statutory stock options to purchase an aggregate of 9.620 shares of its common stock and 11,535 restricted stock units ("RSUs"), each representing the right to receive one share of its common stock upon vesting, to 13 new employees. The awards were made pursuant to the Nasdaq inducement grant exception as a component of the new hires' employment compensation.
Get started
Create a free account to read the full story.